Salima Merani devotes half of her time as lead IP counsel for young technology companies seeking funding and the other half of her time representing technology investment firms. In the past 18 months, Merani has been lead IP counsel in deals worth more than a billion dollars. Most recently, she was lead IP counsel for Ulthera Inc., a medical aesthetics company, for which she spent the last six years building an extensive global patent and trademark portfolio. In June, Ulthera announced its successful acquisition by Merz Pharma Group for $600 million. Merani is past vice chair of the American Intellectual Property Law Association USPTO Inter Partes Patent Proceedings Committee.
What do you like about working in tech?
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
